Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01664923 · BASELINE

Baseline characteristics

Safety and Efficacy Study of Enzalutamide Versus Bicalutamide in Men With Prostate Cancer · Source last updated 2019-01-30

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

denoms
  1. counts
    1. group Id
      BG000
      value
      198
    2. group Id
      BG001
      value
      198
    3. group Id
      BG002
      value
      396
    units
    Participants
groups
  1. description
    Participants received enzalutamide 160 mg, self-administered as four 40-mg capsules, once per day by mouth and 1 bicalutamide-placebo capsule in DB phase.
    id
    BG000
    title
    Enzalutamide
  2. description
    Participants received bicalutamide 50 mg, self-administered as 1 capsule, once per day by mouth and 4 enzalutamide-placebo capsules in DB phase.
    id
    BG001
    title
    Bicalutamide
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          25
        3. group Id
          BG002
          value
          64
        title
        < 65 years
      2. measurements
        1. group Id
          BG000
          value
          82
        2. group Id
          BG001
          value
          76
        3. group Id
          BG002
          value
          158
        title
        65-74 years
      3. measurements
        1. group Id
          BG000
          value
          77
        2. group Id
          BG001
          value
          97
        3. group Id
          BG002
          value
          174
        title
        ≥ 75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          198
        3. group Id
          BG002
          value
          396
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex/Gender, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          198
        3. group Id
          BG002
          value
          396
      title
      United States
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants
Complete source fields
denoms
  1. counts
    1. group Id
      BG000
      value
      198
    2. group Id
      BG001
      value
      198
    3. group Id
      BG002
      value
      396
    units
    Participants
groups
  1. description
    Participants received enzalutamide 160 mg, self-administered as four 40-mg capsules, once per day by mouth and 1 bicalutamide-placebo capsule in DB phase.
    id
    BG000
    title
    Enzalutamide
  2. description
    Participants received bicalutamide 50 mg, self-administered as 1 capsule, once per day by mouth and 4 enzalutamide-placebo capsules in DB phase.
    id
    BG001
    title
    Bicalutamide
  3. description
    Total of all reporting groups
    id
    BG002
    title
    Total
measures
  1. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          39
        2. group Id
          BG001
          value
          25
        3. group Id
          BG002
          value
          64
        title
        < 65 years
      2. measurements
        1. group Id
          BG000
          value
          82
        2. group Id
          BG001
          value
          76
        3. group Id
          BG002
          value
          158
        title
        65-74 years
      3. measurements
        1. group Id
          BG000
          value
          77
        2. group Id
          BG001
          value
          97
        3. group Id
          BG002
          value
          174
        title
        ≥ 75 years
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Age, Customized
    unit Of Measure
    Participants
  2. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          198
        3. group Id
          BG002
          value
          396
        title
        Male
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Sex/Gender, Customized
    unit Of Measure
    Participants
  3. classes
    1. categories
      1. measurements
        1. group Id
          BG000
          value
          198
        2. group Id
          BG001
          value
          198
        3. group Id
          BG002
          value
          396
      title
      United States
    param Type
    COUNT_OF_PARTICIPANTS
    title
    Region of Enrollment
    unit Of Measure
    Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Not medical advice